Catalina Capital Group LLC bought a new stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 11,698 shares of the company’s stock, valued at approximately $220,000.
Several other institutional investors also recently modified their holdings of the business. International Assets Investment Management LLC acquired a new position in shares of Crescent Capital BDC during the 4th quarter worth about $1,254,000. Confluence Investment Management LLC bought a new stake in Crescent Capital BDC in the first quarter valued at approximately $1,200,000. Muzinich & Co. Inc. acquired a new stake in Crescent Capital BDC in the fourth quarter worth $843,000. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Crescent Capital BDC during the fourth quarter worth $843,000. Finally, Mmbg Investment Advisors CO. acquired a new position in shares of Crescent Capital BDC in the 4th quarter valued at $612,000. Institutional investors and hedge funds own 49.46% of the company’s stock.
Analysts Set New Price Targets
Several research firms have weighed in on CCAP. Wells Fargo & Company reduced their target price on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 14th. Keefe, Bruyette & Woods upped their price target on shares of Crescent Capital BDC from $18.50 to $19.00 and gave the company an “outperform” rating in a report on Thursday, May 23rd. Bank of America reduced their target price on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 15th. Finally, Raymond James boosted their price target on Crescent Capital BDC from $18.00 to $19.00 and gave the company an “outperform” rating in a report on Friday, May 10th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $18.80.
Crescent Capital BDC Stock Up 0.4 %
Shares of Crescent Capital BDC stock traded up $0.08 during trading hours on Friday, reaching $18.36. 155,598 shares of the company’s stock were exchanged, compared to its average volume of 140,763. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.11. The company has a 50 day moving average of $18.67 and a two-hundred day moving average of $17.80. The stock has a market cap of $680.46 million, a P/E ratio of 6.53 and a beta of 0.81. Crescent Capital BDC, Inc. has a fifty-two week low of $15.03 and a fifty-two week high of $19.63.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last posted its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.01. Crescent Capital BDC had a return on equity of 11.99% and a net margin of 53.32%. The firm had revenue of $48.95 million during the quarter, compared to the consensus estimate of $48.05 million. During the same period last year, the company earned $0.56 earnings per share. On average, sell-side analysts forecast that Crescent Capital BDC, Inc. will post 2.34 EPS for the current fiscal year.
Crescent Capital BDC Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th will be given a dividend of $0.42 per share. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.09. This represents a $1.68 annualized dividend and a yield of 9.15%. The ex-dividend date of this dividend is Monday, September 30th. Crescent Capital BDC’s dividend payout ratio is 59.79%.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- 3 Warren Buffett Stocks to Buy Now
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- MarketBeat Week in Review – 8/19 – 8/23
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.